Investigation of insulin sensitivity in early diabetes. II. Insulin resistance in asymptomatic diabetics. 1980

B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich

Thirty-eight non-obese and seven obese subjects were classified by a 2-hour glucose infusion test as having a normal carbohydrate tolerance. Sixteen non-obese ad ten obese patients showed a pathological carbohydrate tolerance (asymptomatic diabetes). For the characterization of insulin sensitivity a 1-hour priming dose-constant infusion technique consisting of two 30-minute-periods was applied in all subjects. A decrease of glycemia during this insulin infusion of less than 22.5 per cent has been accepted as a criterion of insulin insensitivity. Sixty-three per cent of non-obese and seventy-eight per cent of obese asymptomatic diabetics exhibited a reduced responsiveness to insulin. There ws an inverse relationship between the per cent decrease of plasma glucose concentration and the insulin secretion pattern revealed by the glucose infusion test. The results suggest that insulin resistance is a characteristic feature of obese and non-obese asymptomatic diabetics.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011236 Prediabetic State The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). Prediabetes,Prediabetic States,State, Prediabetic,States, Prediabetic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
January 1954, Deutsches Archiv fur klinische Medizin,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
January 1952, Deutsches Archiv fur klinische Medizin,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
March 1994, Casopis lekaru ceskych,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
September 2002, Saudi medical journal,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
July 1981, Diabetes,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
January 1950, Acta medica Scandinavica. Supplementum,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
July 1982, Horumon to rinsho. Clinical endocrinology,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
April 1984, Experimental and clinical endocrinology,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
November 1947, The Indian medical gazette,
B Schulz, and K P Ratzmann, and S Witt, and M Anders, and M Ehrlich
January 1990, Advances in second messenger and phosphoprotein research,
Copied contents to your clipboard!